EE+ POEM Archive
Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture
Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture is a topic covered in the EE+ POEM Archive.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
Slawson, David C., et al., editors. "Romosozumab Prevents Clinical Fracture Slightly Better Than Alendronate in Women With Osteoporosis and Previous Fracture." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture.
Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture. In: Slawson DC, Shaughnessy AF, Ebell MH, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture. Accessed August 12, 2020.
Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture. (2019). In Slawson, D. C., Shaughnessy, A. F., Ebell, M. H., & Barry, H. (Eds.), EE+ POEM Archive. John Wiley & Sons. Retrieved August 12, 2020, from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture
Romosozumab Prevents Clinical Fracture Slightly Better Than Alendronate in Women With Osteoporosis and Previous Fracture [Internet]. In: Slawson DC, Shaughnessy AF, Ebell MH, Barry H, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2020 August 12]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Romosozumab prevents clinical fracture slightly better than alendronate in women with osteoporosis and previous fracture
ID - 1314414
ED - Slawson,David C,
ED - Shaughnessy,Allen F,
ED - Ebell,Mark H,
ED - Barry,Henry,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314414/all/Romosozumab_prevents_clinical_fracture_slightly_better_than_alendronate_in_women_with_osteoporosis_and_previous_fracture
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
